.png/:/rs=h:199,cg:true,m/qt=q:95)
Healing: Return to Health
Sinus Healing for Patients & Their Surgeons
Healing: Return to Health
Sinus Healing for Patients & Their Surgeons
About Us
The Problem
Improving Sinus Surgery Outcomes
Improving Sinus Surgery Outcomes
Chronic sinusitis ranks among the most expensive and pervasive medical problems in the modern world, rivalling cardiovascular disease, diabetes, and other adult diseases for intervention and pharmaceutical treatment efforts. Surgical intervention remains destructive and invasive with risks of scar, complication, and revision.
Improving Sinus Surgery Outcomes
Improving Sinus Surgery Outcomes
Improving Sinus Surgery Outcomes
Sinus cavities and their openings, or ostia, must be healthy to allow gas and liquid exchange, proper humidity for respiratory health, wet filtration of the airway, and elimination of microbes and other irritants. Chronic sinusitis results from obstruction of sinus ostia and subsequent accumulation of diseased mucus rather than steady-sta
Sinus cavities and their openings, or ostia, must be healthy to allow gas and liquid exchange, proper humidity for respiratory health, wet filtration of the airway, and elimination of microbes and other irritants. Chronic sinusitis results from obstruction of sinus ostia and subsequent accumulation of diseased mucus rather than steady-state elimination. Surgery is often attempted to reopen the sinus ostia when medical measures fail. Uniform application of a pressure/occlusive dressing in the ostia is challenging due to the irregular contour and window-like opening of the sinus ostia.
The SinuTec Solution
Improving Sinus Surgery Outcomes
The SinuTec Solution
SinuTec has developed a solution to promote healing and durability of sinus interventions, providing a ‘cure’ for inadequate sinus intervention and expanding the usage of procedural sinus treatment to a broader group of sufferers of this impactful disease.
Our Team
John Ashley, CEO
Ed Hepworth, M.D., CMO
Ed Hepworth, M.D., CMO
John has specialized in the development and commercialization of medical technology for the past 30 years. He has a B.S. and M.S. in mechanical engineering from MIT. As a medical device executive, he has led numerous start-ups from funding through profitable exits. His expertise includes guiding new products from concept to commercializat
John has specialized in the development and commercialization of medical technology for the past 30 years. He has a B.S. and M.S. in mechanical engineering from MIT. As a medical device executive, he has led numerous start-ups from funding through profitable exits. His expertise includes guiding new products from concept to commercialization and in setting up and running quality systems, production capabilities, clinical studies, regulatory submissions and regulatory compliance. His start-up companies through acquisitions and IPOs have returned over $1.3B to investors.
Ed Hepworth, M.D., CMO
Ed Hepworth, M.D., CMO
Ed Hepworth, M.D., CMO
Dr. Hepworth is an Otolaryngology (Ear, Nose, & Throat) Specialist fellowship trained at Stanford. He is a nationally recognized contributor to the science and clinical practice of endoscopic sinus and skull base surgery. He is also a chemical engineer/material scientist with experience in the aerospace and atomic energy industries. His e
Dr. Hepworth is an Otolaryngology (Ear, Nose, & Throat) Specialist fellowship trained at Stanford. He is a nationally recognized contributor to the science and clinical practice of endoscopic sinus and skull base surgery. He is also a chemical engineer/material scientist with experience in the aerospace and atomic energy industries. His experience with biomaterials predates his medical experience by more than a decade, first as an aerospace failure analysis engineer and later as a radioactive waste cleanup project manager. Both of these life and career experiences gave him a unique perspective on the nuances of sinus care and how to bring innovative technology solutions to the human experience as provider and patient.
Howard Levine, M.D.
Ed Hepworth, M.D., CMO
Howard Levine, M.D.
Dr. Levine is the Chairmen of the Scientific Advisory Board for SinuTec and a practicing sinus surgeon. He has over 40 years of practice treating patients with chronic rhinosinusitis both in private practice and at the Cleveland Clinic (Head of Section for Nasal and Sinus Disorders) and the Mt Sinai Medical Center (Chief of Nasal and Sinu
Dr. Levine is the Chairmen of the Scientific Advisory Board for SinuTec and a practicing sinus surgeon. He has over 40 years of practice treating patients with chronic rhinosinusitis both in private practice and at the Cleveland Clinic (Head of Section for Nasal and Sinus Disorders) and the Mt Sinai Medical Center (Chief of Nasal and Sinus Surgery). He also held the position of Vice President of Medical Affairs for Acclarent Medical which developed and commercialized a nasal balloon dilation system (Acquired by Johnson and Johnson for$785M). He is providing advice regarding sinus surgeries practices, industry trends and market needs, business relationships, and clinical studies.